AlphaFold predicted structure
MPC2 · O95563

Mean pLDDT
89.4/ 100
Confident
127 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)46%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mitochondrial pyruvate carrier 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalmitochondrial pyruvate carrier deficiency
colorectal carcinoma
MODY
schizophrenia
renal cell carcinoma
melanoma
acute kidney injury
hepatocellular carcinoma
hyperinsulinism due to INSR deficiency
transient neonatal diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mitochondrial pyruvate carrier 2
Mediates the uptake of pyruvate into mitochondria to maintain the balance between glycolysis and oxidative phosphorylation (PubMed:22628558, PubMed:26253029, PubMed:27317664, PubMed:29472561, PubMed:40044865, PubMed:40101766, PubMed:35278701). Plays an essential role in cellular metabolism (PubMed:40044865, PubMed:40101766)
MPC2 · O95563

Mean pLDDT
89.4/ 100
Confident
127 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0